ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Hayloc, Krebs Lead Oncology Nurses

May 16, 1997

Prostatectomy Improves Outcome In Some Men

August 29, 2008

Tumor Treating Fields Therapy Increased Three-Year Survival

November 25, 2011

DCE Board Approves concept For New Studies On Black, White Differences In Cancer Rates

July 13, 1984

NCI Programs; Pediatric Brain Tumor Consortium Approved In Concepts By BSA; Concepts For Resource Of Arrayed BAC Clones, Support For Radiation Therapy Trials, OH’d

November 23, 1997

ASCO Writes A New Mission Statement Placing Emphasis On Helping Patients

May 21, 1999